Cargando…
Intraoperative administration of Hextend(®) versus 6% Hetastrach in saline for the treatment of hypovolemia during major surgery: preliminary results of a randomized clinical trial
Autores principales: | Bennett-Guerrero, E, Gan, TJ, Moskowitz, DM, Booth, JV, Konstadt, S, Olefulobi, Y, Bradford, C, Kucmeroski, D, Woolf, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301316/ http://dx.doi.org/10.1186/cc204 |
Ejemplares similares
-
Intraoperative hypovolemia as a possible precipitating factor for pituitary apoplexy: a case report
por: Abo, Kristine M., et al.
Publicado: (2023) -
Perioperative clinical and economic outcomes associated with replacing first-generation high molecular weight hydroxyethyl starch (Hextend®) with low molecular weight hydroxyethyl starch (Voluven®) at a large medical center
por: Bartz, Raquel R, et al.
Publicado: (2015) -
Hypovolemia with peripheral edema: What is wrong?
por: Dull, Randal O., et al.
Publicado: (2023) -
The Brody effect to detect hypovolemia in clinical practice
por: Giraud, R, et al.
Publicado: (2012) -
Cerebrospinal fluid hypovolemia syndrome with benign course
por: Ramesha, K. N., et al.
Publicado: (2010)